These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 4400826)
21. Anesthesia. XXXIX. The in vitro studies of the influence on adenosine triphosphate (ATP) dephosphorylation by central depressants and stimulants. LU G; KRANTZ JC Anesthesiology; 1953 Jul; 14(4):348-58. PubMed ID: 13058163 [No Abstract] [Full Text] [Related]
23. Mechanism of action and therapeutic uses of psychostimulants. Foley KF Clin Lab Sci; 2005; 18(2):107-13. PubMed ID: 15916243 [No Abstract] [Full Text] [Related]
24. Basic actions of psychoactive drugs. Carlsson A Int J Neurol; 1967; 6(1):27-45. PubMed ID: 4392241 [No Abstract] [Full Text] [Related]
25. [Biochemistry and psychiatry]. Bickel MH Schweiz Med Wochenschr; 1967 Sep; 97(36):1167-73. PubMed ID: 4385790 [No Abstract] [Full Text] [Related]
26. [Experimental study of a new psycho-stimulating agent: magnesium pemoline]. Faglioni P; De Renzi E; Pieczuro A Sist Nerv; 1966; 18(3):165-9. PubMed ID: 4381006 [No Abstract] [Full Text] [Related]
27. Phencyclidine, ketamine, and khat phencyclidine (PCP, DOA, 'angel dust', 'crystal', 'hog'). O'Shea B Ir Med J; 2000 Sep; 93(6):185. PubMed ID: 11105446 [No Abstract] [Full Text] [Related]
28. The analeptic action of 1-n-butylamino-3-p-toluidino-2-propanol (W181) in mephenesin paralysis. BERGER FM J Pharmacol Exp Ther; 1953 Feb; 107(2):250-7. PubMed ID: 13035663 [No Abstract] [Full Text] [Related]
29. Behavioral changes and aggressivity evoked by drugs in mice. Krsiak M Res Commun Chem Pathol Pharmacol; 1974 Feb; 7(2):237-57. PubMed ID: 4150439 [No Abstract] [Full Text] [Related]
30. Stimulus properties of hallucinogenic phenalkylamines and related designer drugs: formulation of structure-activity relationships. Glennon RA NIDA Res Monogr; 1989; 94():43-67. PubMed ID: 2575229 [No Abstract] [Full Text] [Related]
31. Pharmacological properties of Su-19789B, a unique central nervous system stimulant. Chernov HI; Wilson DE; Partyka DA; Bernard PS; Huebner CF Arch Int Pharmacodyn Ther; 1970 Mar; 184(1):34-44. PubMed ID: 4393633 [No Abstract] [Full Text] [Related]
32. [Pharmacotherapy of psychoses and psychoreactive disturbances]. Liedtke U; Schilling R Landarzt; 1967 Feb; 43(6):252-62. PubMed ID: 4385548 [No Abstract] [Full Text] [Related]
33. [Contribution to the study of the central effects of hallucinogenic and psychotomimetic medicines]. Longo VG Actual Neurophysiol (Paris); 1967; 7():203-16. PubMed ID: 6043096 [No Abstract] [Full Text] [Related]
34. [Effect of alkyl derivatives of cysteamine and cystamine and some aminoalkyldisulfides on central nervous system]. Smaĭlene AA; Slavachevskaia NM Farmakol Toksikol; 1970; 33(3):271-5. PubMed ID: 4393830 [No Abstract] [Full Text] [Related]
35. Phenylalkylamine stimulants, hallucinogens, and designer drugs. Glennon RA NIDA Res Monogr; 1990; 105():154-60. PubMed ID: 1678860 [TBL] [Abstract][Full Text] [Related]
36. [Bioelectric potentials of the brain under the action of psychopharmaca]. Dordević D Vojnosanit Pregl; 1968 Apr; 25(4):193-6. PubMed ID: 4386166 [No Abstract] [Full Text] [Related]
37. Drugs and the mental state. Smith SE Nurs Times; 1972 Aug; 68(32):1001-2. PubMed ID: 5045338 [No Abstract] [Full Text] [Related]
38. Pharmacology of the central nervous system. Shellenberger MK; Walaszek E Prog Neurol Psychiatry; 1970; 25():106-29. PubMed ID: 4395104 [No Abstract] [Full Text] [Related]
39. News in chemistry of psychotropic drugs in the year 1969. Protiva M Act Nerv Super (Praha); 1970; 12(3):193-214. PubMed ID: 4394019 [No Abstract] [Full Text] [Related]
40. [Studies on the psychic effect of a central stimulant after various degrees of psychic stress]. Janke W; Amelang M Psychol Forsch; 1965 Dec; 28(6):562-86. PubMed ID: 4380049 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]